The global Mycosis Fungoides Therapeutics market was valued at US$ 538.5 million in 2023 and is anticipated to reach US$ 730.8 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.

Mycosis Fungoides Therapeutics Market

Mycosis fungoides is the most common type of cutaneous T-cell lymphoma and there is an increase in its incidence of mycosis fungoides.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Mycosis Fungoides Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycosis Fungoides Therapeutics.

Report Scope

The Mycosis Fungoides Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mycosis Fungoides Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mycosis Fungoides Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Mycosis Fungoides Therapeutics Market Report

Report Metric	Details
Report Name	Mycosis Fungoides Therapeutics Market
Accounted market size in 2023	US$ 538.5 million
Forecasted market size in 2030	US$ 730.8 million
CAGR	4.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Small Molecules Biologics
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Azurity Pharmaceuticals Inc., Celgene Corp., Eisai Co. Ltd., Helsinn Healthcare SA, Horizon Therapeutics Plc, Kyowa Kirin Co. Ltd., Merck & Co. Inc., Seattle Genetics Inc., Soligenix Inc., Takeda Pharmaceutical Co. Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mycosis Fungoides Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Mycosis Fungoides Therapeutics Market growing?

Ans: The Mycosis Fungoides Therapeutics Market witnessing a CAGR of 4.4% during the forecast period 2024-2030.

What is the Mycosis Fungoides Therapeutics Market size in 2030?

Ans: The Mycosis Fungoides Therapeutics Market size in 2030 will be US$ 730.8 million.

Who are the main players in the Mycosis Fungoides Therapeutics Market report?

Ans: The main players in the Mycosis Fungoides Therapeutics Market are Azurity Pharmaceuticals Inc., Celgene Corp., Eisai Co. Ltd., Helsinn Healthcare SA, Horizon Therapeutics Plc, Kyowa Kirin Co. Ltd., Merck & Co. Inc., Seattle Genetics Inc., Soligenix Inc., Takeda Pharmaceutical Co. Ltd.

What are the Application segmentation covered in the Mycosis Fungoides Therapeutics Market report?

Ans: The Applications covered in the Mycosis Fungoides Therapeutics Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Mycosis Fungoides Therapeutics Market report?

Ans: The Types covered in the Mycosis Fungoides Therapeutics Market report are Small Molecules, Biologics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Mycosis Fungoides Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Small Molecules

1.2.3 Biologics

1.3 Market by Application

1.3.1 Global Mycosis Fungoides Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Mycosis Fungoides Therapeutics Market Perspective (2019-2030)

2.2 Mycosis Fungoides Therapeutics Growth Trends by Region

2.2.1 Global Mycosis Fungoides Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Mycosis Fungoides Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Mycosis Fungoides Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Mycosis Fungoides Therapeutics Market Dynamics

2.3.1 Mycosis Fungoides Therapeutics Industry Trends

2.3.2 Mycosis Fungoides Therapeutics Market Drivers

2.3.3 Mycosis Fungoides Therapeutics Market Challenges

2.3.4 Mycosis Fungoides Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Mycosis Fungoides Therapeutics Players by Revenue

3.1.1 Global Top Mycosis Fungoides Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Mycosis Fungoides Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Mycosis Fungoides Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Mycosis Fungoides Therapeutics Revenue

3.4 Global Mycosis Fungoides Therapeutics Market Concentration Ratio

3.4.1 Global Mycosis Fungoides Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Mycosis Fungoides Therapeutics Revenue in 2023

3.5 Mycosis Fungoides Therapeutics Key Players Head office and Area Served

3.6 Key Players Mycosis Fungoides Therapeutics Product Solution and Service

3.7 Date of Enter into Mycosis Fungoides Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Mycosis Fungoides Therapeutics Breakdown Data by Type

4.1 Global Mycosis Fungoides Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Mycosis Fungoides Therapeutics Forecasted Market Size by Type (2025-2030)

5 Mycosis Fungoides Therapeutics Breakdown Data by Application

5.1 Global Mycosis Fungoides Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Mycosis Fungoides Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Mycosis Fungoides Therapeutics Market Size (2019-2030)

6.2 North America Mycosis Fungoides Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Mycosis Fungoides Therapeutics Market Size by Country (2019-2024)

6.4 North America Mycosis Fungoides Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Mycosis Fungoides Therapeutics Market Size (2019-2030)

7.2 Europe Mycosis Fungoides Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Mycosis Fungoides Therapeutics Market Size by Country (2019-2024)

7.4 Europe Mycosis Fungoides Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Mycosis Fungoides Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Mycosis Fungoides Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Mycosis Fungoides Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Mycosis Fungoides Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Mycosis Fungoides Therapeutics Market Size (2019-2030)

9.2 Latin America Mycosis Fungoides Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Mycosis Fungoides Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Mycosis Fungoides Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Mycosis Fungoides Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Mycosis Fungoides Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Mycosis Fungoides Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Mycosis Fungoides Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Azurity Pharmaceuticals Inc.

11.1.1 Azurity Pharmaceuticals Inc. Company Detail

11.1.2 Azurity Pharmaceuticals Inc. Business Overview

11.1.3 Azurity Pharmaceuticals Inc. Mycosis Fungoides Therapeutics Introduction

11.1.4 Azurity Pharmaceuticals Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.1.5 Azurity Pharmaceuticals Inc. Recent Development

11.2 Celgene Corp.

11.2.1 Celgene Corp. Company Detail

11.2.2 Celgene Corp. Business Overview

11.2.3 Celgene Corp. Mycosis Fungoides Therapeutics Introduction

11.2.4 Celgene Corp. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.2.5 Celgene Corp. Recent Development

11.3 Eisai Co. Ltd.

11.3.1 Eisai Co. Ltd. Company Detail

11.3.2 Eisai Co. Ltd. Business Overview

11.3.3 Eisai Co. Ltd. Mycosis Fungoides Therapeutics Introduction

11.3.4 Eisai Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.3.5 Eisai Co. Ltd. Recent Development

11.4 Helsinn Healthcare SA

11.4.1 Helsinn Healthcare SA Company Detail

11.4.2 Helsinn Healthcare SA Business Overview

11.4.3 Helsinn Healthcare SA Mycosis Fungoides Therapeutics Introduction

11.4.4 Helsinn Healthcare SA Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.4.5 Helsinn Healthcare SA Recent Development

11.5 Horizon Therapeutics Plc

11.5.1 Horizon Therapeutics Plc Company Detail

11.5.2 Horizon Therapeutics Plc Business Overview

11.5.3 Horizon Therapeutics Plc Mycosis Fungoides Therapeutics Introduction

11.5.4 Horizon Therapeutics Plc Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.5.5 Horizon Therapeutics Plc Recent Development

11.6 Kyowa Kirin Co. Ltd.

11.6.1 Kyowa Kirin Co. Ltd. Company Detail

11.6.2 Kyowa Kirin Co. Ltd. Business Overview

11.6.3 Kyowa Kirin Co. Ltd. Mycosis Fungoides Therapeutics Introduction

11.6.4 Kyowa Kirin Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.6.5 Kyowa Kirin Co. Ltd. Recent Development

11.7 Merck & Co. Inc.

11.7.1 Merck & Co. Inc. Company Detail

11.7.2 Merck & Co. Inc. Business Overview

11.7.3 Merck & Co. Inc. Mycosis Fungoides Therapeutics Introduction

11.7.4 Merck & Co. Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.7.5 Merck & Co. Inc. Recent Development

11.8 Seattle Genetics Inc.

11.8.1 Seattle Genetics Inc. Company Detail

11.8.2 Seattle Genetics Inc. Business Overview

11.8.3 Seattle Genetics Inc. Mycosis Fungoides Therapeutics Introduction

11.8.4 Seattle Genetics Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.8.5 Seattle Genetics Inc. Recent Development

11.9 Soligenix Inc.

11.9.1 Soligenix Inc. Company Detail

11.9.2 Soligenix Inc. Business Overview

11.9.3 Soligenix Inc. Mycosis Fungoides Therapeutics Introduction

11.9.4 Soligenix Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.9.5 Soligenix Inc. Recent Development

11.10 Takeda Pharmaceutical Co. Ltd.

11.10.1 Takeda Pharmaceutical Co. Ltd. Company Detail

11.10.2 Takeda Pharmaceutical Co. Ltd. Business Overview

11.10.3 Takeda Pharmaceutical Co. Ltd. Mycosis Fungoides Therapeutics Introduction

11.10.4 Takeda Pharmaceutical Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024)

11.10.5 Takeda Pharmaceutical Co. Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Azurity Pharmaceuticals Inc.

Celgene Corp

Eisai Co Ltd

Helsinn Healthcare SA

Horizon Therapeutics plc

Kyowa Kirin Co., Ltd.

Merck& Co. Inc

Seattle Genetics Inc

Soligenix Inc

Takeda Pharmaceutical Co Ltd

List of Tables

Table 1. Global Mycosis Fungoides Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Small Molecules

Table 3. Key Players of Biologics

Table 4. Global Mycosis Fungoides Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Mycosis Fungoides Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Mycosis Fungoides Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Mycosis Fungoides Therapeutics Market Share by Region (2019-2024)

Table 8. Global Mycosis Fungoides Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Mycosis Fungoides Therapeutics Market Share by Region (2025-2030)

Table 10. Mycosis Fungoides Therapeutics Market Trends

Table 11. Mycosis Fungoides Therapeutics Market Drivers

Table 12. Mycosis Fungoides Therapeutics Market Challenges

Table 13. Mycosis Fungoides Therapeutics Market Restraints

Table 14. Global Mycosis Fungoides Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Mycosis Fungoides Therapeutics Market Share by Players (2019-2024)

Table 16. Global Top Mycosis Fungoides Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycosis Fungoides Therapeutics as of 2023)

Table 17. Ranking of Global Top Mycosis Fungoides Therapeutics Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Mycosis Fungoides Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Mycosis Fungoides Therapeutics Product Solution and Service

Table 21. Date of Enter into Mycosis Fungoides Therapeutics Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Mycosis Fungoides Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Mycosis Fungoides Therapeutics Revenue Market Share by Type (2019-2024)

Table 25. Global Mycosis Fungoides Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Mycosis Fungoides Therapeutics Revenue Market Share by Type (2025-2030)

Table 27. Global Mycosis Fungoides Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Mycosis Fungoides Therapeutics Revenue Market Share by Application (2019-2024)

Table 29. Global Mycosis Fungoides Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Mycosis Fungoides Therapeutics Revenue Market Share by Application (2025-2030)

Table 31. North America Mycosis Fungoides Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Mycosis Fungoides Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Mycosis Fungoides Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Mycosis Fungoides Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Mycosis Fungoides Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Mycosis Fungoides Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Mycosis Fungoides Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Mycosis Fungoides Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Mycosis Fungoides Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Mycosis Fungoides Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Mycosis Fungoides Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Mycosis Fungoides Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Mycosis Fungoides Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Mycosis Fungoides Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Mycosis Fungoides Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. Azurity Pharmaceuticals Inc. Company Detail

Table 47. Azurity Pharmaceuticals Inc. Business Overview

Table 48. Azurity Pharmaceuticals Inc. Mycosis Fungoides Therapeutics Product

Table 49. Azurity Pharmaceuticals Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 50. Azurity Pharmaceuticals Inc. Recent Development

Table 51. Celgene Corp. Company Detail

Table 52. Celgene Corp. Business Overview

Table 53. Celgene Corp. Mycosis Fungoides Therapeutics Product

Table 54. Celgene Corp. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 55. Celgene Corp. Recent Development

Table 56. Eisai Co. Ltd. Company Detail

Table 57. Eisai Co. Ltd. Business Overview

Table 58. Eisai Co. Ltd. Mycosis Fungoides Therapeutics Product

Table 59. Eisai Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 60. Eisai Co. Ltd. Recent Development

Table 61. Helsinn Healthcare SA Company Detail

Table 62. Helsinn Healthcare SA Business Overview

Table 63. Helsinn Healthcare SA Mycosis Fungoides Therapeutics Product

Table 64. Helsinn Healthcare SA Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 65. Helsinn Healthcare SA Recent Development

Table 66. Horizon Therapeutics Plc Company Detail

Table 67. Horizon Therapeutics Plc Business Overview

Table 68. Horizon Therapeutics Plc Mycosis Fungoides Therapeutics Product

Table 69. Horizon Therapeutics Plc Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 70. Horizon Therapeutics Plc Recent Development

Table 71. Kyowa Kirin Co. Ltd. Company Detail

Table 72. Kyowa Kirin Co. Ltd. Business Overview

Table 73. Kyowa Kirin Co. Ltd. Mycosis Fungoides Therapeutics Product

Table 74. Kyowa Kirin Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 75. Kyowa Kirin Co. Ltd. Recent Development

Table 76. Merck & Co. Inc. Company Detail

Table 77. Merck & Co. Inc. Business Overview

Table 78. Merck & Co. Inc. Mycosis Fungoides Therapeutics Product

Table 79. Merck & Co. Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 80. Merck & Co. Inc. Recent Development

Table 81. Seattle Genetics Inc. Company Detail

Table 82. Seattle Genetics Inc. Business Overview

Table 83. Seattle Genetics Inc. Mycosis Fungoides Therapeutics Product

Table 84. Seattle Genetics Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 85. Seattle Genetics Inc. Recent Development

Table 86. Soligenix Inc. Company Detail

Table 87. Soligenix Inc. Business Overview

Table 88. Soligenix Inc. Mycosis Fungoides Therapeutics Product

Table 89. Soligenix Inc. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 90. Soligenix Inc. Recent Development

Table 91. Takeda Pharmaceutical Co. Ltd. Company Detail

Table 92. Takeda Pharmaceutical Co. Ltd. Business Overview

Table 93. Takeda Pharmaceutical Co. Ltd. Mycosis Fungoides Therapeutics Product

Table 94. Takeda Pharmaceutical Co. Ltd. Revenue in Mycosis Fungoides Therapeutics Business (2019-2024) & (US$ Million)

Table 95. Takeda Pharmaceutical Co. Ltd. Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Mycosis Fungoides Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Mycosis Fungoides Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Small Molecules Features

Figure 4. Biologics Features

Figure 5. Global Mycosis Fungoides Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Mycosis Fungoides Therapeutics Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Clinic Case Studies

Figure 9. Other Case Studies

Figure 10. Mycosis Fungoides Therapeutics Report Years Considered

Figure 11. Global Mycosis Fungoides Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Mycosis Fungoides Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Mycosis Fungoides Therapeutics Market Share by Region: 2023 VS 2030

Figure 14. Global Mycosis Fungoides Therapeutics Market Share by Players in 2023

Figure 15. Global Top Mycosis Fungoides Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycosis Fungoides Therapeutics as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Mycosis Fungoides Therapeutics Revenue in 2023

Figure 17. North America Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Mycosis Fungoides Therapeutics Market Share by Country (2019-2030)

Figure 19. United States Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Mycosis Fungoides Therapeutics Market Share by Country (2019-2030)

Figure 23. Germany Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Mycosis Fungoides Therapeutics Market Share by Region (2019-2030)

Figure 31. China Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Mycosis Fungoides Therapeutics Market Share by Country (2019-2030)

Figure 39. Mexico Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Mycosis Fungoides Therapeutics Market Share by Country (2019-2030)

Figure 43. Turkey Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Mycosis Fungoides Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Azurity Pharmaceuticals Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 46. Celgene Corp. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 47. Eisai Co. Ltd. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 48. Helsinn Healthcare SA Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 49. Horizon Therapeutics Plc Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 50. Kyowa Kirin Co. Ltd. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 51. Merck & Co. Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 52. Seattle Genetics Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 53. Soligenix Inc. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 54. Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Mycosis Fungoides Therapeutics Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions